SOPHARMA AD: current report 124 inf. za kfn11.2012 ENG

opublikowano: 2012-12-05 14:15

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
current_report_124_inf._za_kfn11.2012_ENG.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 124 / 2012
Date of issue: 2012-12-05
Short name of the issuer
SOPHARMA AD
Subject
current report 124 inf. za kfn11.2012 ENG
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
The Board of Directors of Sopharma AD (the “Company") notifies that for November 2012 sales revenues remained at the same level compared to the same period of 2011, including 1% increase of export sales and no changes in domestic sales.
During the first eleven months of this year Sopharma AD recorded an increase of sales revenues of 2%, including 9% decrease of domestic sales and 6% increase of export sales compared to the same period of 2011.


Annexes
File Description
current report 124 inf. za kfn11.2012 ENG.doccurrent report 124 inf. za kfn11.2012 ENG.doc current report 124 inf. za kfn11.2012 ENG

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2012-12-05 Ognian Donev Executive Director